癌症研究
癌变
生物
癌症
表观遗传学
肿瘤进展
遗传学
基因
作者
Xufeng Lu,Dazhuan Xin,Juanjuan K. Du,Quanli C. Zou,Qian Wu,Yanan S. Zhang,Wenhai Deng,Jicheng Yue,Xing S. Fan,Yuanyuan Zeng,Xiaju Cheng,Xue Li,Zhaoyuan Hou,Man Mohan,Ting C. Zhao,Xiaomei Lu,Zhijie Chang,Li‐Yan Xu,Yu Sun,Xiongbing Zu
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2022-10-04
卷期号:82 (23): 4400-4413
被引量:33
标识
DOI:10.1158/0008-5472.can-22-0848
摘要
LOXL2 loss reprograms the epigenetic landscape to promote uterine cancer initiation and progression and repress the efficacy of anti-PD-1 immunotherapy, indicating that LOXL2 is a tumor suppressor.
科研通智能强力驱动
Strongly Powered by AbleSci AI